HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $761 | +36.1% | 12,550 | -82.3% | 0.08% | 0.0% |
Q2 2023 | $559 | +126.3% | 70,928 | +1264.0% | 0.08% | +212.0% |
Q1 2023 | $247 | -87.0% | 5,200 | -93.5% | 0.02% | -84.4% |
Q4 2022 | $1,897 | +89.7% | 80,037 | +15907.4% | 0.16% | – |
Q3 2022 | $1,000 | -95.7% | 500 | -58.3% | 0.00% | -100.0% |
Q2 2022 | $23,000 | -99.3% | 1,200 | -98.3% | 0.00% | -98.9% |
Q1 2022 | $3,417,000 | +238.0% | 68,769 | +256.4% | 0.18% | +328.6% |
Q4 2021 | $1,011,000 | -29.8% | 19,295 | -22.8% | 0.04% | -34.4% |
Q3 2021 | $1,441,000 | +835.7% | 25,006 | +482.2% | 0.06% | +700.0% |
Q2 2021 | $154,000 | +81.2% | 4,295 | -82.8% | 0.01% | +100.0% |
Q1 2021 | $85,000 | -90.6% | 25,000 | -15.3% | 0.00% | -90.7% |
Q4 2020 | $908,000 | +29.2% | 29,533 | -22.9% | 0.04% | -2.3% |
Q3 2020 | $703,000 | +7711.1% | 38,300 | +3091.7% | 0.04% | +4300.0% |
Q2 2020 | $9,000 | -88.9% | 1,200 | -60.0% | 0.00% | -85.7% |
Q3 2019 | $81,000 | -15.6% | 3,000 | -25.0% | 0.01% | -22.2% |
Q2 2019 | $96,000 | – | 4,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |